{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:05:42Z","timestamp":1793379942207,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["BWF1012376"],"award-info":[{"award-number":["BWF1012376"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI126033"],"award-info":[{"award-number":["AI126033"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI138949"],"award-info":[{"award-number":["AI138949"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI165499"],"award-info":[{"award-number":["AI165499"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI142572"],"award-info":[{"award-number":["R01AI142572"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI146101"],"award-info":[{"award-number":["R01AI146101"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI153064"],"award-info":[{"award-number":["R01AI153064"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI168312"],"award-info":[{"award-number":["R01AI168312"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI137433"],"award-info":[{"award-number":["R21AI137433"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ymthe.2023.07.022","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T03:20:10Z","timestamp":1690946410000},"page":"2702-2714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Development of an mRNA-lipid nanoparticle vaccine against Lyme disease"],"prefix":"10.1016","volume":"31","author":[{"given":"Matthew","family":"Pine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Gaudette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Tomb\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Kambayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Brisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Locci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"Fikrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-6242","authenticated-orcid":false,"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.07.022_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.idc.2015.02.010","article-title":"Epidemiology of Lyme disease","volume":"29","author":"Mead","year":"2015","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.ymthe.2023.07.022_bib2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid2108.141878","article-title":"Geographic Distribution and Expansion of Human Lyme Disease, United States","volume":"21","author":"Kugeler","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010-2018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.idc.2015.02.001","article-title":"Erythema Migrans","volume":"29","author":"Nadelman","year":"2015","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.ymthe.2023.07.022_bib5","first-page":"e14","article-title":"Misdiagnosis of early Lyme disease as the summer flu","volume":"3","author":"Aucott","year":"2011","journal-title":"Orthop. Rev."},{"key":"10.1016\/j.ymthe.2023.07.022_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2174\/1874205X01206010140","article-title":"Issues in the diagnosis and treatment of Lyme disease","volume":"6","author":"Donta","year":"2012","journal-title":"Open Neurol. J."},{"key":"10.1016\/j.ymthe.2023.07.022_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cll.2010.01.003","article-title":"Lyme Disease","volume":"30","author":"Murray","year":"2010","journal-title":"Clin. Lab. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib8","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1114362","article-title":"Differentiation of Reinfection from Relapse in Recurrent Lyme Disease","volume":"367","author":"Nadelman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib9","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1128\/IAI.67.8.3929-3936.1999","article-title":"Plasmin-coated borrelia Burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix","volume":"67","author":"Coleman","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2023.07.022_bib10","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.micinf.2005.08.017","article-title":"Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinity","volume":"8","author":"Lagal","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2023.07.022_bib11","doi-asserted-by":"crossref","first-page":"16860","DOI":"10.1074\/jbc.M111.290775","article-title":"OspC is potent plasminogen receptor on surface of Borrelia burgdorferi","volume":"287","author":"\u00d6nder","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.07.022_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrmicro2714","article-title":"Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes","volume":"10","author":"Radolf","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme borreliosis","volume":"2","author":"Steere","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2023.07.022_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fimmu.2017.00116","article-title":"Borrelia burgdorferi Manipulates Innate and Adaptive Immunity to Establish Persistence in Rodent Reservoir Hosts","volume":"8","author":"Tracy","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib15","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.92.7.2909","article-title":"Induction of an outer surface protein on Borrelia burgdorferi during tick feeding","volume":"92","author":"Schwan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.07.022_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-695X.2012.00980.x","article-title":"The role of Borrelia burgdorferi outer surface proteins","volume":"66","author":"Kenedy","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1186\/s12879-015-1190-7","article-title":"Public health impact of strain specific immunity to Borrelia burgdorferi","volume":"15","author":"Khatchikian","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1126\/science.2237407","article-title":"Protection of mice against the Lyme disease agent by immunizing with recombinant OspA","volume":"250","author":"Fikrig","year":"1990","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ymthe.2023.07.022_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199807233390401","article-title":"Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group","volume":"339","author":"Steere","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.281.5377.703","article-title":"Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis","volume":"281","author":"Gross","year":"1998","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ymthe.2023.07.022_bib21","doi-asserted-by":"crossref","first-page":"s259","DOI":"10.1093\/cid\/ciq117","article-title":"Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis","volume":"52","author":"Steere","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0950268806007096","article-title":"The Lyme vaccine: a cautionary tale","volume":"135","author":"Nigrovic","year":"2007","journal-title":"Epidemiol. Infec"},{"key":"10.1016\/j.ymthe.2023.07.022_bib23","first-page":"136","article-title":"Blocking pathogen transmission at the source: reservoir targeted OspA-based vaccines against Borrelia burgdorferi","volume":"4","author":"Gomes-Solecki","year":"2014","journal-title":"Front. Cel. Infect. Microbiol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12917-018-1625-7","article-title":"Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters","volume":"14","author":"Grosenbaugh","year":"2018","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.ymthe.2023.07.022_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.tvjl.2021.105676","article-title":"Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines","volume":"273","author":"Camire","year":"2021","journal-title":"Vet. J."},{"key":"10.1016\/j.ymthe.2023.07.022_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00917-19","article-title":"Broadly Protective Multivalent OspA Vaccine against Lyme Borreliosis, Developed Based on Surface Shaping of the C-Terminal Fragment.","volume":"88","author":"Nayak","year":"2020","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2023.07.022_bib27","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/cid\/ciz872","article-title":"Protective Immunity and New Vaccines for Lyme Disease","volume":"70","author":"Gomes-Solecki","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.07.022_bib29","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1038\/s41467-018-05482-0","article-title":"Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies","volume":"9","author":"Pardi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.07.022_bib30","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1038\/s41467-022-32149-8","article-title":"Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses","volume":"13","author":"Pardi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2023.07.022_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206333119","article-title":"Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses","volume":"119","author":"McMahon","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.07.022_bib32","first-page":"111","article-title":"Messenger RNA-Based Vaccines Against Infectious Diseases","volume":"440","author":"Alameh","year":"2022","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2023.07.022_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA Vaccines in the COVID-19 Pandemic and Beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2023.07.022_bib36","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib37","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1002\/eji.200425485","article-title":"Frontline: An in-depth evaluation of the production of IL-2 by antigen-specific CD8 T\u00a0cells in\u00a0vivo","volume":"34","author":"D'Souza","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib38","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","article-title":"SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation","volume":"53","author":"Lederer","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.07.022_bib40","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.07.022_bib41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.cell.2022.01.027","article-title":"Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals","volume":"185","author":"Lederer","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.07.022_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101840","article-title":"A combined fine needle aspiration and spectral flow cytometry approach to assess human germinal center responses to SARS-CoV-2 vaccination","volume":"3","author":"Bettini","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ymthe.2023.07.022_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.immuni.2010.10.008","article-title":"From vaccines to memory and back","volume":"33","author":"Sallusto","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.07.022_bib44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice","volume":"53","author":"Laczk\u00f3","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.07.022_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009030","article-title":"A human secretome library screen reveals a role for Peptidoglycan Recognition Protein 1 in Lyme borreliosis","volume":"16","author":"Gupta","year":"2020","journal-title":"Plos Pathog."},{"key":"10.1016\/j.ymthe.2023.07.022_bib46","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/vbz.2017.2127","article-title":"Brave New Worlds: The Expanding Universe of Lyme Disease","volume":"17","author":"Stone","year":"2017","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.666554","article-title":"Recent Progress in Lyme Disease and Remaining Challenges","volume":"8","author":"Bobe","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"An epidemic of oligoarticular arthritis in children and adults in three connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ymthe.2023.07.022_bib49","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1172\/JCI138062","article-title":"Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses","volume":"130","author":"Steere","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.07.022_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fmed.2020.00057","article-title":"Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease","volume":"7","author":"Rebman","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib51","doi-asserted-by":"crossref","first-page":"s271","DOI":"10.1093\/cid\/ciq119","article-title":"Correcting a public health fiasco: The need for a new vaccine against Lyme disease","volume":"52","author":"Plotkin","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184357","article-title":"The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes","volume":"12","author":"Comstedt","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.07.022_bib53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-022-00429-5","article-title":"The year that shaped the outcome of the OspA vaccine for human Lyme disease","volume":"7","author":"Dattwyler","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2023.07.022_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113294","article-title":"Design and development of a novel vaccine for protection against Lyme borreliosis","volume":"9","author":"Comstedt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.07.022_bib55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaw7083","article-title":"Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes","volume":"4","author":"Awasthi","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2023.07.022_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41541-021-00345-0","article-title":"Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice","volume":"6","author":"Mallory","year":"2021","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2023.07.022_bib58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41541-022-00577-8","article-title":"mRNA-LNP expressing PfCSP and Pfs25 vaccine candidates targeting infection and transmission of Plasmodium falciparum","volume":"7","author":"Hayashi","year":"2022","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2023.07.022_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj9827","article-title":"mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent","volume":"13","author":"Sajid","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib60","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1016\/j.vaccine.2021.11.003","article-title":"Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies","volume":"39","author":"Matias","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2023.07.022_bib61","doi-asserted-by":"crossref","first-page":"eadg1036","DOI":"10.1126\/sciadv.adg1036","article-title":"A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium","volume":"9","author":"Kon","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.ymthe.2023.07.022_bib62","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/vaccines10050751","article-title":"Vaccination against Bacterial Infections: Challenges, Progress, and New Approaches with a Focus on Intracellular Bacteria","volume":"10","author":"Osterloh","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2023.07.022_bib63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1568005014606026","article-title":"Vaccines for parasitic diseases","volume":"1","author":"Price","year":"2001","journal-title":"Curr. Drug Targets Infect. Disord."},{"key":"10.1016\/j.ymthe.2023.07.022_bib64","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0168-6445(03)00036-6","article-title":"Adaptation of Borrelia burgdorferi in the tick and the mammalian host","volume":"27","author":"Anguita","year":"2003","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2023.07.022_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.183.1.271","article-title":"Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine","volume":"183","author":"de Silva","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ymthe.2023.07.022_bib66","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/iai.60.3.773-777.1992","article-title":"Long-term protection of mice from Lyme disease by vaccination with OspA","volume":"60","author":"Fikrig","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2023.07.022_bib67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/vbz.2012.1003","article-title":"Reductions in human Lyme disease risk due to the effects of oral vaccination on tick-to-mouse and mouse-to-tick transmission","volume":"13","author":"Voordouw","year":"2013","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","article-title":"A Facile Method for the Removal of dsRNA Contaminant from In\u00a0Vitro-Transcribed mRNA","volume":"15","author":"Baiersd\u00f6rfer","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2023.07.022_bib69","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.ymthe.2023.07.022_bib70","article-title":"A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues","volume":"11","author":"Yu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.07.022_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00062-22","article-title":"CspZ FH-Binding Sites as Epitopes Promote Antibody-Mediated Lyme Borreliae Clearance","volume":"90","author":"Chen","year":"2022","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2023.07.022_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ttbdis.2022.102081","article-title":"Outer surface protein E (OspE) mediates Borrelia burgdorferi sensu stricto strain-specific complement evasion in the eastern fence lizard, Sceloporus undulatus","volume":"14","author":"Nowak","year":"2023","journal-title":"Ticks Tick. Borne. Dis."},{"key":"10.1016\/j.ymthe.2023.07.022_bib73","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/IAI.69.5.3224-3231.2001","article-title":"C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes","volume":"69","author":"Liang","year":"2001","journal-title":"Infect. Immun."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623004288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623004288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:09:05Z","timestamp":1761502145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623004288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1525001623004288"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.022","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an mRNA-lipid nanoparticle vaccine against Lyme disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}